204 related articles for article (PubMed ID: 25113791)
1. A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
Chiofalo MG; Sparaneo A; Chetta M; Franco R; Baorda F; Cinque L; Granatiero M; D'Agruma L; Pezzullo L; Scillitani A; Guarnieri V
Cell Oncol (Dordr); 2014 Aug; 37(4):281-8. PubMed ID: 25113791
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
3. Large intragenic deletion of CDC73 (exons 4-10) in a three-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family.
Guarnieri V; Seaberg RM; Kelly C; Jean Davidson M; Raphael S; Shuen AY; Baorda F; Palumbo O; Scillitani A; Hendy GN; Cole DEC
BMC Med Genet; 2017 Aug; 18(1):83. PubMed ID: 28774260
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
5. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
6. A Novel Mutation in a Patient with Hyperparathyroidism-Jaw Tumour Syndrome.
Bellido V; Larrañaga I; Guimón M; Martinez-Conde R; Eguia A; Perez de Nanclares G; Castaño L; Gaztambide S
Endocr Pathol; 2016 Jun; 27(2):142-6. PubMed ID: 26995009
[TBL] [Abstract][Full Text] [Related]
7. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
8. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the N-terminal domain of human CDC73 and its implications for the hyperparathyroidism-jaw tumor (HPT-JT) syndrome.
Sun W; Kuang XL; Liu YP; Tian LF; Yan XX; Xu W
Sci Rep; 2017 Nov; 7(1):15638. PubMed ID: 29142233
[TBL] [Abstract][Full Text] [Related]
10. Insights into Hyperparathyroidism-Jaw Tumour Syndrome: From Endocrine Acumen to the Spectrum of
Gheorghe AM; Sima OC; Florescu AF; Ciuche A; Nistor C; Sandru F; Carsote M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396977
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
12. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
[TBL] [Abstract][Full Text] [Related]
13. CDC73 intragenic deletion in familial primary hyperparathyroidism associated with parathyroid carcinoma.
Korpi-Hyövälti E; Cranston T; Ryhänen E; Arola J; Aittomäki K; Sane T; Thakker RV; Schalin-Jäntti C
J Clin Endocrinol Metab; 2014 Sep; 99(9):3044-8. PubMed ID: 24823466
[TBL] [Abstract][Full Text] [Related]
14. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
16. A two-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
[TBL] [Abstract][Full Text] [Related]
17. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ; Bowl MR; Cranston T; Thakker RV
Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
[TBL] [Abstract][Full Text] [Related]
18. A large extended family with hyperparathyroidism-jaw tumor syndrome due to deletion of the third exon of CDC73: clinical and molecular features.
Le Collen L; Barraud S; Braconnier A; Coppin L; Zachar D; Boulagnon C; Deguelte S; Souchon PF; Spodenkiewicz M; Poirsier C; Aubert S; Odou MF; Delemer B
Endocrine; 2021 Sep; 73(3):693-701. PubMed ID: 33999366
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 gene.
Pazienza V; la Torre A; Baorda F; Alfarano M; Chetta M; Muscarella LA; Battista C; Copetti M; Kotzot D; Kapelari K; Al-Abdulrazzaq D; Perlman K; Sochett E; Cole DE; Pellegrini F; Canaff L; Hendy GN; D'Agruma L; Zelante L; Carella M; Scillitani A; Guarnieri V
PLoS One; 2013; 8(12):e82292. PubMed ID: 24340015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
